SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-190147
Filing Date
2023-07-20
Accepted
2023-07-20 08:04:51
Documents
14
Period of Report
2023-07-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d517183d8k.htm   iXBRL 8-K 44980
2 EX-99.1 d517183dex991.htm EX-99.1 24936
6 GRAPHIC g517183g0720053517084.jpg GRAPHIC 2340
  Complete submission text file 0001193125-23-190147.txt   205962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vir-20230720.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20230720_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20230720_pre.xml EX-101.PRE 11252
8 EXTRACTED XBRL INSTANCE DOCUMENT d517183d8k_htm.xml XML 3346
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 231098122
SIC: 2836 Biological Products, (No Diagnostic Substances)